GE Healthcare
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, GE Healthcare sits in the top decile of US sponsors by registered trial count (#242 of 15,742 sponsors by registered trial count).
GE Healthcare: 99 sponsored US clinical trials, 8 recruiting.
GE Healthcare sponsors 99 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 61 completed. 23 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 2 trials.
Top-decile sponsor footprint
GE Healthcare ranks in the top decile of sponsors by registered trial count (#242 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
61 of 90 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (67.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
99 total, page 1 of 2
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
NCT07219238
NMT EasyFit Sensor and Cable
NCT07394140
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
NCT07472491
Data Collection of New Spectral CT Imaging Method
NCT07661706
GSI Cardiac on Revolution Apex - US
NCT06702917
Next Generation CT System
NCT06769594
Maternal Fetal Device Performance Twins
NCT06835647
Clinical Feasibility and Evaluation of Silicon Photon Counting CT
NCT05838482
SpO2 Infant and Pediatric Study
NCT07615738
Maternal Fetal Device Performance Singleton
NCT06726343
A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers
NCT06398730
Evaluation of the Goldcrest Patch Performance
NCT06355453
Wireless Disposable SpO2 Sensor Hypoxia Testing
NCT06211530
Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
NCT05949138
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
NCT05636852
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
NCT05068726
GE CVUS Device Evaluation
NCT05340244
A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes
NCT04594941
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
NCT03740997
Automated Breast Ultrasound Case Collection Registry
NCT03417024
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
NCT03354273
A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease
NCT03119662
Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow
NCT03456427
Vscan Access R2 Feasibility Evaluation
NCT03617419
Patient-Assisted Compression - Impact on Image Quality and Workflow
NCT03196635
Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
NCT02972892
Performance of the Monica Novii Wireless Patch System in Pre-term Labor
NCT03057275
Clinical Evaluation Of MP26 Features in Adults
NCT02927327
Data Collection for Next Generation Ultrasound Technology Development
NCT02946229
Image Quality Assessment for Screening and Diagnostic Mammography
NCT02786004
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
NCT02656329
Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images
NCT02596854
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
NCT02556177
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography
NCT02540083
Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
NCT02232009
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography
NCT02306265
Non-invasive Quantification of Liver Iron With MRI
NCT02425956
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)
NCT02324205
TBI MR Study 3 Houston Methodist
NCT02218216
Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
NCT02141360
Accuracy and Reliability of Novii: Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contraction (UA) Compared With Doppler, Scalp Fetal Scalp Electrode (FSE), Tocodynamometer (TOCO) and Intra Uterine Pressure Catheter (IUPC)
NCT03409146
Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations
NCT02125331
Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts
NCT02042456
Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.
NCT02127307
Advanced MRI Applications for Mild Traumatic Brain Injury
NCT02070588
Comparison of 18F FDG PET/CT TO PET MRI
NCT01986985
Development of an Integrated Positron Emission Tomography/Magnetic Resonance (PET/MR) System, Accessories and Components
NCT01992354
Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
NCT02090855
A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senographe Essential
NCT01885143
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
NCT01936649
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 10 |
| Phase 3 | 12 |
| Phase 4 | 11 |
Where GE Healthcare enrollment is open (later-stage tilt)
8 recruiting of 99 indexed (8% open); 61 completed (62%).
Phase mix: 23 late (III/IV) vs 14 early (I/II) (later-stage heavy).
Top condition: Breast Cancer (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
GE Healthcare: open-pipeline peers nationwide
Peers matched on 99 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
GE Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 99 trials (± recruiting share)
- UCB Pharma · 100 trials · 0% recruiting
- Wake Forest University · 100 trials · 7% recruiting
- Creighton University · 98 trials · 5% recruiting
- Spaulding Rehabilitation Hospital · 101 trials · 19% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Oregon Research Institute · 8% recruiting · 62 trials
- National Eye Institute (NEI) · 8% recruiting · 221 trials
- Arcutis Biotherapeutics · 8% recruiting · 25 trials
- Medtronic Endovascular · 8% recruiting · 25 trials
Related
What to do with this GE Healthcare page
99 registered trials is a research-attention snapshot, not an endorsement of GE Healthcare or any single study.
- 8 of GE Healthcare's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition GE Healthcare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. GE Healthcare pipeline card: 99 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.